NCT00876122View on ClinicalTrials.gov

A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
Non-Hodgkin's Lymphoma, Solid Cancers
Interventions
DRUG

GDC-0941

Escalating oral dose

Trial Locations (1)

SM2 5PT

Sutton

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00876122 - A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable | Biotech Hunter | Biotech Hunter